Renaissance Technologies’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-887,740
| Closed | -$2.36M | – | 4109 |
|
|
2024
Q1 | $2.36M | Buy |
887,740
+312,761
| +54% | +$832K | ﹤0.01% | 1925 |
|
|
2023
Q4 | $1.36M | Buy |
574,979
+69,023
| +14% | +$164K | ﹤0.01% | 2204 |
|
|
2023
Q3 | $708K | Buy |
505,956
+168,156
| +50% | +$235K | ﹤0.01% | 2534 |
|
|
2023
Q2 | $1.02M | Buy |
337,800
+227,300
| +206% | +$689K | ﹤0.01% | 2455 |
|
|
2023
Q1 | $691K | Buy |
110,500
+7,100
| +7% | +$44.4K | ﹤0.01% | 2699 |
|
|
2022
Q4 | $631K | Buy |
103,400
+2,900
| +3% | +$17.7K | ﹤0.01% | 2808 |
|
|
2022
Q3 | $1.2M | Buy |
100,500
+4,900
| +5% | +$58.6K | ﹤0.01% | 2384 |
|
|
2022
Q2 | $1.21M | Buy |
95,600
+71,700
| +300% | +$905K | ﹤0.01% | 2585 |
|
|
2022
Q1 | $269K | Buy |
+23,900
| New | +$269K | ﹤0.01% | 3519 |
|
|
2021
Q4 | – | Sell |
-23,358
| Closed | -$538K | – | 4310 |
|
|
2021
Q3 | $538K | Sell |
23,358
-12,542
| -35% | -$289K | ﹤0.01% | 2860 |
|
|
2021
Q2 | $836K | Buy |
+35,900
| New | +$836K | ﹤0.01% | 2760 |
|